SMTL ID : 6cz4.1

Structure of the PTK6 kinase domain bound to a type II inhibitor 2-{[(3R,4S)-3-fluoro-1-{[4-(trifluoromethoxy)phenyl]acetyl}piperidin-4-yl]oxy}-5-(1-methyl-1H-imidazol-4-yl)pyridine-3-carboxamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x FKY: 2-{[(3R,4S)-3-fluoro-1-{[4-(trifluoromethoxy)phenyl]acetyl}piperidin-4-yl]oxy}-5-(1-methyl-1H-imidazol-4-yl)pyridine-3-carboxamide(Non-covalent)

FKY.1: 23 residues within 4Å: Chain A: L.18, V.26, A.38, M.60, L.63, I.68, L.69, T.85, E.86, L.87, M.88, A.89, K.90, G.91, L.124, Y.129, H.131, L.140, V.149, G.150, D.151, F.152, L.154 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.18, A:D.151, A:F.152, A:L.154 Hydrogen bonds: A:E.86, A:M.88, A:D.151 Halogen bonds: A:V.149

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Qiu, L. et al., Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers. PLoS ONE (2018)

Release Date

2018-06-20

Peptides

Protein-tyrosine kinase 6: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Protein-tyrosine kinase 6

Related Entries With Identical Sequence